论文部分内容阅读
本刊投稿须知刊登在当年第1期,请投稿者遵照写稿。1征稿内容《中国新药与临床杂志》是集中报道国内外新药的全国性医药科技学术期刊,着重报道药物的临床研究和临床应用,介绍国内外新药的进展及动态。主要登载:(1)新药(包括老药新用)的临床试验(Ⅰ期、Ⅱ期、Ⅲ期、Ⅳ期);(2)生物等效性试验;(3)新药临床前研究(药理、毒理、药动学、稳定性等);(4)药物的临床应用、基础药理、临床药理;(5)药物不良反应及监测;(6)合理用药、相互作用与评价;(7)新药的进展和动态;等等。新药评审申报的临床研究资料经整理改写后可投本刊。本刊欢迎英文稿。
Articles published in the first issue of the year for contributors to follow the manuscript. 1 Contents of the Call The Journal of New Drugs and Clinical Medicine of China is a national academic journal of medical science and technology focusing on new drugs at home and abroad. It focuses on the clinical research and clinical application of drugs, and introduces the progress and dynamics of new drugs at home and abroad. (2) Bioequivalence test; (3) Pre-clinical study of new drugs (pharmacology, pharmacology, pharmacology, Toxicology, pharmacokinetics, stability, etc.); (4) the clinical application of drugs, basic pharmacology, clinical pharmacology; (5) adverse drug reactions and monitoring; (6) rational drug use, interaction and evaluation; Progress and dynamics; and so on. New drug review and reporting of clinical research data after finishing can be cast investment magazine. Our welcome English version.